Showing results (801-810 of 847) with videos related to

Sort By:
Pageof 85
JNCI Cancer Spectrum|October 15, 2025
Short-term surgical outcomes in patients with early- versus average-onset colon adenocarcinoma in the Military Health SystemYvonne L Eaglehouse, Sarah Darmon, Robert W Krell, et al.
JNCI Cancer Spectrum|May 23, 2025
Implementing social and behavioral determinants of health data collection: insights from a pragmatic trialKriyana P Reddy, Saania Mirpuri, Cara L Berkowitz, et al.
JNCI Cancer Spectrum|July 21, 2025
Extending catchment area approaches to a community cancer center: a breast cancer hotspot case studyScott D Siegel, Yuchen Zhang, Ross Budziszewski, et al.
JNCI Cancer Spectrum|July 23, 2025
Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatmentP Travis Courtney, Jesus E Juarez Casillas, Eulanca Y Liu, et al.
JNCI Cancer Spectrum|May 30, 2025
Socioeconomic disparities and bladder cancer stage at diagnosis: a statewide cohort analysisAlessio Finocchiaro, Anna Tylecki, Silvia Viganò, et al.
JNCI Cancer Spectrum|May 9, 2025
Leveraging geospatial data to support an implementation science approach to address lung cancer burdenTesla D Dubois, Alison C Brecher, Donna Edmondson, et al.
JNCI Cancer Spectrum|November 10, 2025
Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLERUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
JNCI Cancer Spectrum|October 21, 2025
Effects of aerobic exercise on late effects and quality of life in long-term breast cancer survivors: a randomized controlled trialSara Hassing Johansen, Kristin V Reinertsen, Torbjørn Wisløff, et al.
JNCI Cancer Spectrum|August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysisFrancesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.
JNCI Cancer Spectrum|August 14, 2025
REaCT-5G: a randomized trial of bone pain with 5-day-filgrastim vs. pegfilgrastim for neutropenia in breast cancerTerry L Ng, Peter Greenstreet, Carol Stober, et al.
Pageof 85